Today: 21 May 2026
Browse Category

Mergers and Acquisitions 15 December 2025 - 26 December 2025

Zeta Global (ZETA) Stock Today: Marigold Deal, AI-Agent Momentum, and Wall Street Targets as Markets Reopen After Christmas

Zeta Global (ZETA) Stock Today: Marigold Deal, AI-Agent Momentum, and Wall Street Targets as Markets Reopen After Christmas

Zeta Global Holdings traded near $19.12 late Friday morning, little changed after opening at $19.05. The stock showed muted movement as U.S. markets reopened post-Christmas with light volume. Investors continue to weigh Zeta’s recent $325 million Marigold acquisition and raised guidance ahead of CES 2026.
26 December 2025
···
AI Stocks Today (Dec. 25, 2025): Nvidia’s Groq Deal, Snowflake’s M&A Talks, UiPath’s Index Boost, and Meta’s WhatsApp AI Clash

AI Stocks Today (Dec. 25, 2025): Nvidia’s Groq Deal, Snowflake’s M&A Talks, UiPath’s Index Boost, and Meta’s WhatsApp AI Clash

Nvidia has secured a non-exclusive license to Groq’s AI inference chip technology and is hiring Groq’s founder, president, and key engineers, Reuters reports. Groq will continue operating independently under a new CEO. Snowflake is reportedly in talks to acquire Observe for about $1 billion, according to Investors.com, in what would be its largest deal to date.
25 December 2025
······
AI Stocks Today (Dec. 24, 2025, 5:02 p.m. ET): Nvidia’s Reported $20B Groq Deal, Snowflake M&A Talk, and Wall Street’s 2026 AI Outlook

AI Stocks Today (Dec. 24, 2025, 5:02 p.m. ET): Nvidia’s Reported $20B Groq Deal, Snowflake M&A Talk, and Wall Street’s 2026 AI Outlook

Nvidia agreed to acquire AI chip startup Groq for $20 billion in cash, Reuters reported Wednesday, citing CNBC. The S&P 500 and Dow closed at record highs after an early Christmas Eve session, lifted by renewed demand for tech and AI stocks and expectations of Fed rate cuts in 2026. Trading volumes were thin ahead of the holiday.
24 December 2025
··
Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Sanofi announced a deal to acquire Dynavax Technologies for $2.2 billion in cash, offering $15.50 per share—a 39% premium to Dynavax’s prior close. DVAX stock jumped about 37% premarket to near the offer price. Dynavax’s board approved the transaction. Closing is expected in Q1 2026, pending regulatory and shareholder approvals.
24 December 2025
···
Clearwater Analytics (CWAN) Stock News on Dec. 23, 2025: $24.55 Take-Private Deal, Go‑Shop Window, Analyst Reactions, and What Investors Should Watch

Clearwater Analytics (CWAN) Stock News on Dec. 23, 2025: $24.55 Take-Private Deal, Go‑Shop Window, Analyst Reactions, and What Investors Should Watch

Clearwater Analytics shares traded at $24.06 on December 23, just below the $24.55-per-share cash buyout price set in an $8.4 billion take-private deal led by Permira and Warburg Pincus. The agreement includes a go-shop period through January 23, 2026, allowing Clearwater to seek higher offers.
23 December 2025
·
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

BioMarin agreed to acquire Amicus Therapeutics for $14.50 per share in cash, valuing Amicus at $4.8 billion. FOLD traded near $14.22 on December 22, reflecting market expectations for deal completion and timing. The transaction is expected to close in Q2 2026, pending regulatory and shareholder approvals. Either party may terminate if not closed by June 19, 2026, with a $175 million breakup fee.
22 December 2025
··
ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effect

ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effect

Abivax shares jumped as much as 14% to €114.4 in Paris on Monday after reports of renewed takeover interest from Eli Lilly and the company’s addition to the Nasdaq Biotechnology Index. French outlet La Lettre reported Lilly representatives met with French Treasury officials this month about a potential deal, though Reuters said it could not confirm the meeting. Neither company commented on the rumors.
22 December 2025
··
ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

Abivax shares jumped about 10% to $126 in early U.S. premarket trading after reports of renewed takeover speculation involving Eli Lilly and confirmation of Abivax’s addition to the Nasdaq Biotechnology Index. French media said Lilly representatives met with France’s Treasury about a possible acquisition, though Reuters could not confirm the meeting. Both companies declined to comment on the rumors.
22 December 2025
····
Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

BioMarin Pharmaceutical agreed Friday to acquire Amicus Therapeutics for $14.50 per share in cash, valuing the company at $4.8 billion. FOLD shares closed near $14.18 after jumping 30% on the news. The deal is expected to close in Q2 2026, pending shareholder and regulatory approvals. Amicus disclosed a $175 million breakup fee and a June 19, 2026 outside date.
22 December 2025
····
ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow shares traded near $155 (split-adjusted) as of December 21, 2025, after a volatile week driven by reports of advanced talks to acquire Armis for up to $7 billion. The stock fell sharply on December 15 amid concerns over the deal’s size and a key analyst downgrade. ServiceNow recently completed a 5-for-1 stock split and closed its largest acquisition to date, Moveworks. No formal confirmation of the Armis deal has been issued.
21 December 2025
··
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Latest News, Analyst Forecasts, and What Comes Next (Dec. 21, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Latest News, Analyst Forecasts, and What Comes Next (Dec. 21, 2025)

BioMarin Pharmaceutical agreed to acquire Amicus Therapeutics for $14.50 per share in cash, valuing Amicus at $4.8 billion. Amicus closed at $14.20 on Dec. 19, just below the buyout price. The deal, approved by both boards, is expected to close in Q2 2026 pending regulatory and shareholder approval. BioMarin plans to fund the purchase with cash and about $3.7 billion in new debt.
21 December 2025
··
Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

BioMarin Pharmaceutical will acquire Amicus Therapeutics in an all-cash deal valued at $4.8 billion, offering $14.50 per share. Amicus stock surged about 30% after the Dec. 19 announcement, trading near $14.18 as of Dec. 20. The deal awaits regulatory and shareholder approval, with closing expected in Q2 2026. Trading volume spiked as investors focused on merger risk and timing.
21 December 2025
··
Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery’s board urged shareholders to reject Paramount Skydance’s $30-per-share all-cash tender offer, citing financing concerns and a potential $4.3 billion cost if the Netflix deal is abandoned. WBD stock closed at $27.77 on Dec. 19, near Netflix’s $27.75 per-share offer. Netflix reaffirmed its commitment to its $72 billion deal. Paramount continues to push its cash bid.
21 December 2025
···
Communication Services Stocks News Today (Dec. 20, 2025): Meta, Alphabet, Netflix–Warner Deal Shockwaves, and Telecom M&A Set Up 2026

Communication Services Stocks News Today (Dec. 20, 2025): Meta, Alphabet, Netflix–Warner Deal Shockwaves, and Telecom M&A Set Up 2026

Meta’s board lost Dina Powell McCormick after eight months, with no replacement planned, Reuters reported Dec. 19. Facebook is testing link-sharing limits for non-paying users, according to the Guardian. The XLC ETF’s top holdings remain Meta and Alphabet, with Warner Bros. Discovery now among the largest entertainment weights. Recent XLC net asset value sits near $116.
20 December 2025
··········
Qualcomm (QCOM) Stock News Today: Alphawave Semi Acquisition Closes, Analyst Targets Update, and 2026 AI Data-Center Outlook (Dec. 19, 2025)

Qualcomm (QCOM) Stock News Today: Alphawave Semi Acquisition Closes, Analyst Targets Update, and 2026 AI Data-Center Outlook (Dec. 19, 2025)

Qualcomm closed its $2.4 billion acquisition of Alphawave Semi on December 19, ahead of schedule, and named Alphawave CEO Tony Pialis to lead its data center business. Alphawave shares were delisted from the London Stock Exchange Friday morning. Qualcomm stock rose 1.37% to $176.58 as investors weighed the deal’s impact and debated the company’s valuation.
19 December 2025
··
Howard Hughes Holdings (HHH) Stock Falls on Dec. 19, 2025 After $2.1B Vantage Deal: Latest News, Analyst Forecasts, and Key Risks

Howard Hughes Holdings (HHH) Stock Falls on Dec. 19, 2025 After $2.1B Vantage Deal: Latest News, Analyst Forecasts, and Key Risks

Howard Hughes Holdings shares fell about 5% to $79–$80 on Friday after announcing a $2.1 billion deal to acquire Vantage Group Holdings. The company will finance the purchase with cash and up to $1 billion in preferred stock issued to Pershing Square. The deal is expected to close in Q2 2026, pending regulatory approvals. Investors reacted to the company’s shift toward a diversified holding model.
19 December 2025
··
TWO-PA Stock News Today (Dec. 17, 2025): UWM’s $1.3B Two Harbors Deal Puts Series A Preferred in Focus — What Holders Need to Know

TWO-PA Stock News Today (Dec. 17, 2025): UWM’s $1.3B Two Harbors Deal Puts Series A Preferred in Focus — What Holders Need to Know

UWM Holdings will acquire Two Harbors Investment Corp. in an all-stock deal valued at $1.3 billion, the companies announced December 17. Each Two Harbors Series A preferred share (TWO-PA) will be exchanged one-for-one into a newly issued UWM Series A preferred share at closing, expected in Q2 2026 pending approvals. Common shareholders will receive 2.3328 UWMC shares per TWO share.
17 December 2025
···
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

Abivax shares fell about 5% in U.S. and Paris trading after reporting a nine-month net loss of €254.1 million, up from €136.9 million a year earlier. Cash and cash equivalents stood at €589.7 million as of September 30, expected to fund operations into Q4 2027. Investors weighed widening losses against a strong cash position and ongoing takeover speculation.
16 December 2025
···
Coca-Cola Stock (NYSE: KO) News Today: Costa Coffee Sale Talks, CEO Succession, Dividend, and Analyst Price Targets (Dec. 15, 2025)

Coca-Cola Stock (NYSE: KO) News Today: Costa Coffee Sale Talks, CEO Succession, Dividend, and Analyst Price Targets (Dec. 15, 2025)

Coca-Cola shares traded near $70.72 on Dec. 15, 2025, up 0.28% in a narrow range. Reuters reports last-ditch talks with TDR Capital over a potential Costa Coffee sale, with price disagreements threatening the deal. The company is also managing a CEO transition and a dividend payout. Wall Street maintains a modestly positive outlook for KO.
15 December 2025
··
ServiceNow (NOW) Stock Slides on Armis Deal Rumors, KeyBanc Downgrade, and a Looming 5-for-1 Split

ServiceNow (NOW) Stock Slides on Armis Deal Rumors, KeyBanc Downgrade, and a Looming 5-for-1 Split

ServiceNow shares fell about 11% to $767 Monday after reports the company is in advanced talks to acquire cybersecurity startup Armis for up to $7 billion. The drop followed a KeyBanc analyst downgrade citing AI disruption risks. The selloff comes days before ServiceNow’s planned 5-for-1 stock split. ServiceNow declined to comment on the reported deal.
15 December 2025
··
1 2 3 4 5 … 7

Stock Market Today

  • Planet Labs Nears Sustainable Profitability Amid Industry Challenges
    May 21, 2026, 3:12 PM EDT. Planet Labs (PL) operates a vast network of Earth observation satellites capturing global images daily. Despite technological advances and expanded roles in defense and agriculture, the company has yet to secure steady profits due to high costs in satellite manufacturing, launches, maintenance, and R&D. Revenue growth lags behind fixed costs, while long government sales cycles delay cash flow. Management's 2026 guidance shows optimism, focusing on cost control, vertical specialization, and software monetization to enhance margins. Industry peers Rocket Lab (RKLB) and BlackSky Technology (BKSY) face similar profitability challenges. PL's stock has surged 117% year-to-date but trades at a lofty price-to-sales ratio of 31.38, far above the industry average of 3.86, reflecting high investor expectations amid ongoing financial pressures.

Latest articles

Nebius Shares Surge 15% After $2.6 Billion AI Power Plan Announced

Nebius Shares Surge 15% After $2.6 Billion AI Power Plan Announced

21 May 2026
Nebius Group N.V. shares surged 15.6% to $221.72 after announcing a fuel cell power deal with Bloom Energy, securing up to 328 MW of on-site electricity capacity for its AI infrastructure. The agreement could cost Nebius up to $2.6 billion over 10 years. Bloom shares rose 12.2% on the news. Nebius's first-quarter revenue jumped to $399 million from $50.9 million a year earlier.
Sirius XM stock nears new highs as traders look at audio strategy

Sirius XM stock nears new highs as traders look at audio strategy

21 May 2026
Sirius XM shares rose 6.8% to $28.90 by 2:07 p.m. EDT Thursday, outpacing major U.S. indexes. The rally followed CFO Zac Coughlin’s investor conference appearance and news of a renewed multi-year NASCAR broadcast deal. First-quarter subscriber losses were smaller than expected, and revenue topped forecasts. Volume reached 4.8 million shares, with a market value near $9.8 billion.
KEEL Surges as Investors Back Keel’s AI Data Center Plans

KEEL Surges as Investors Back Keel’s AI Data Center Plans

21 May 2026
Keel Infrastructure shares jumped 7.1% to $4.53 Thursday, nearing a 52-week high, as investors bet on its pivot from crypto mining to AI-focused power infrastructure. Trading volume reached 22.31 million shares, below average. The company reported a wider net loss of $145.35 million for the March quarter on lower revenue and warned its transformation faces risks tied to permits, costs, and competition.
Go toTop